| HOME >> BIOLOGY >> TECHNOLOGY |
Japan, Europe, and Rest of World for Years 2003, 2009 & 2015
(includes corresponding Graph/Chart) 129
Analytics by Application 130
Table 37: World Recent Past, Current & Future Analysis for
Nanobiotechnology by Application - Pharmaceuticals, Medical
Devices, Medical Research and Others Independently Analyzed
with Annual Revenue Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 130
Table 38: World 9-Year Perspective for Nanobiotechnology by
Application - Percentage Breakdown of Revenues for
Pharmaceuticals, Medical Devices, Medical Research and Others
for Years 2007, 2009 & 2015 (includes corresponding
Graph/Chart) 131
12. THE UNITED STATES 132
A.Market Analysis 132
Outlook 132
Industry Overview 132
Public Sector Funding 132
Major Nanobiotechnology Institutions and Centers 133
The Nanobiotechnology Center (NBTC) 133
Key technological advances achieved by NBTC in recent years - 133
Principal NBTC Partners 133
Centre for Biologic Nanotechnology (CBN) 134
Centre for Biological and Environmental Nanotechnology (CBEN) 134
Regulatory Environment 135
B.Market Analytics 136
Table 39: US Recent Past, Current & Future Analysis for
Nanobiotechnology by Technology Segment - Nanomaterials
(Solid Inorganic Nanoparticles, Nanocomposites,
Nanostructured Materials & Membranes, Nanotubes and
Fullerenes, Other Nanomaterials) and Nanodevices/ Tools
Markets Independently Analyzed with Annual Revenue Figures
in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 136
Table 40: US Historic Review for Nanobiotechnology by
Technology Segment - Nanomaterials (Solid Inorganic
Nanoparticles, Nanocompos
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |